13F Holdings
中文EN

AGTX Agentix Corp.

Biological Products, (No Diagnostic Substances) · OTC · SEC CIK 1603345 · Fiscal year ends 03/31

Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY44.4%
TTM EPS YoY0.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-10,542.6%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets290,269.6%
Debt / equity—
Current ratio0.00x
Interest coverage-3.57x

Cash quality & payout

Operating cash flow / net income0.06x
Accruals ratio-9,875.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-31FY20252025-03-31FY20242024-03-31FY20232023-03-31FY20222022-03-31
Income statement
Revenue———$0$1,240
Cost of revenue———$0$561
Gross profit———$0$679
R&D expense$125,079$180,987$175,268$711,506$279,912
SG&A expense$68,072$69,898$346,543$140,012$165,355
Operating income-$445,187-$513,251-$744,810-$1.37M-$2.63M
Interest expense$80,106$42,669$21,034$1,643$0
Pretax income-$485,636-$567,048-$585,154-$1.37M-$2.63M
Income tax$0$0$0$0$0
Net income-$485,636-$567,048-$585,154-$1.37M-$2.63M
EPS (diluted)-0.01-0.01-0.01——
Weighted avg. shares (diluted)40.07M40.07M40.07M——
Balance sheet
Cash & equivalents$771$4,477$6,535$12,369$145
Inventory————$0
Current assets$771$100,274$106,372$261,392$15,978
Total assets$771$100,274$106,372$261,392$15,978
Current liabilities$3.60M$3.20M$2.67M$2.51M$1.09M
Total liabilities$3.60M$3.20M$2.67M$2.51M$1.09M
Shareholders' equity-$3.60M-$3.10M-$2.56M-$2.25M-$1.08M
Shares outstanding40.07M40.07M40.07M40.07M38.92M
Cash flow statement
Operating cash flow-$108,529-$125,078-$110,429-$88,541-$25,204
Investing cash flow$0$0$0$0$0
Financing cash flow$110,450$100,000$93,000$100,000$0

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.